We acknowledge that genetic testing for women with a clinical diagnosis of Rett syndrome has important roles to play, but a proportion of those in our cohort who were older had not been tested for a MECP2 mutation because of its relative recent availability and some families do not now want to revisit diagnostic processes. This evidence concerns the gene MECP2 and atypical Rett syndrome.